ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Assisted Reproductive Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-13U13778
Home | Market Reports | Health| Reproductive Health
Global Assisted Reproductive Drugs Market Research Report 2023
BUY CHAPTERS

Global Assisted Reproductive Drugs Market Research Report 2025

Code: QYRE-Auto-13U13778
Report
May 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck Serono
MSD
Livzon Pharmaceutical
Xianju Pharmaceutical
Kinsey Pharmaceuticals

Assisted Reproductive Drugs Market Size

The global market for Assisted Reproductive Drugs was valued at US$ 699 million in the year 2024 and is projected to reach a revised size of US$ 926 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Assisted Reproductive Drugs Market

Assisted Reproductive Drugs Market

Assisted reproductive drugs include ovulation-stimulating drugs, luteal support drugs, down-regulatory drugs, ovulation-inducing drugs, etc. From the perspective of the use of various drugs in the IVF process, ovulation-stimulating drugs accounted for the highest proportion, as high as 62%, luteal support drugs accounted for 20%, down-regulatory drugs accounted for 15%, and ovulation-inducing drugs accounted for 3%.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Drugs.
The Assisted Reproductive Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Assisted Reproductive Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Assisted Reproductive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Assisted Reproductive Drugs Market Report

Report Metric Details
Report Name Assisted Reproductive Drugs Market
Accounted market size in year US$ 699 million
Forecasted market size in 2031 US$ 926 million
CAGR 4.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Research Institute
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Serono, MSD, Livzon Pharmaceutical, Xianju Pharmaceutical, Kinsey Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Assisted Reproductive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Assisted Reproductive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Assisted Reproductive Drugs Market growing?

Ans: The Assisted Reproductive Drugs Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Assisted Reproductive Drugs Market size in 2031?

Ans: The Assisted Reproductive Drugs Market size in 2031 will be US$ 926 million.

Who are the main players in the Assisted Reproductive Drugs Market report?

Ans: The main players in the Assisted Reproductive Drugs Market are Merck Serono, MSD, Livzon Pharmaceutical, Xianju Pharmaceutical, Kinsey Pharmaceuticals

What are the Application segmentation covered in the Assisted Reproductive Drugs Market report?

Ans: The Applications covered in the Assisted Reproductive Drugs Market report are Hospital, Research Institute, Others

What are the Type segmentation covered in the Assisted Reproductive Drugs Market report?

Ans: The Types covered in the Assisted Reproductive Drugs Market report are Ovulation Stimulation Drugs, Luteal Support Medications, Downregulatory Drugs, Ovulation Inducing Drugs

Recommended Reports

Reproductive Health Drugs

Diagnostics & Monitoring

General Pharma Markets

1 Assisted Reproductive Drugs Market Overview
1.1 Product Definition
1.2 Assisted Reproductive Drugs by Type
1.2.1 Global Assisted Reproductive Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ovulation Stimulation Drugs
1.2.3 Luteal Support Medications
1.2.4 Downregulatory Drugs
1.2.5 Ovulation Inducing Drugs
1.3 Assisted Reproductive Drugs by Application
1.3.1 Global Assisted Reproductive Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Assisted Reproductive Drugs Market Size Estimates and Forecasts
1.4.1 Global Assisted Reproductive Drugs Revenue 2020-2031
1.4.2 Global Assisted Reproductive Drugs Sales 2020-2031
1.4.3 Global Assisted Reproductive Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Assisted Reproductive Drugs Market Competition by Manufacturers
2.1 Global Assisted Reproductive Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Assisted Reproductive Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Assisted Reproductive Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Assisted Reproductive Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Assisted Reproductive Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Assisted Reproductive Drugs, Product Type & Application
2.7 Global Key Manufacturers of Assisted Reproductive Drugs, Date of Enter into This Industry
2.8 Global Assisted Reproductive Drugs Market Competitive Situation and Trends
2.8.1 Global Assisted Reproductive Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Assisted Reproductive Drugs Players Market Share by Revenue
2.8.3 Global Assisted Reproductive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Assisted Reproductive Drugs Market Scenario by Region
3.1 Global Assisted Reproductive Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Assisted Reproductive Drugs Sales by Region: 2020-2031
3.2.1 Global Assisted Reproductive Drugs Sales by Region: 2020-2025
3.2.2 Global Assisted Reproductive Drugs Sales by Region: 2026-2031
3.3 Global Assisted Reproductive Drugs Revenue by Region: 2020-2031
3.3.1 Global Assisted Reproductive Drugs Revenue by Region: 2020-2025
3.3.2 Global Assisted Reproductive Drugs Revenue by Region: 2026-2031
3.4 North America Assisted Reproductive Drugs Market Facts & Figures by Country
3.4.1 North America Assisted Reproductive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Assisted Reproductive Drugs Sales by Country (2020-2031)
3.4.3 North America Assisted Reproductive Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Assisted Reproductive Drugs Market Facts & Figures by Country
3.5.1 Europe Assisted Reproductive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Assisted Reproductive Drugs Sales by Country (2020-2031)
3.5.3 Europe Assisted Reproductive Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Assisted Reproductive Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Assisted Reproductive Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Assisted Reproductive Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Assisted Reproductive Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Assisted Reproductive Drugs Market Facts & Figures by Country
3.7.1 Latin America Assisted Reproductive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Assisted Reproductive Drugs Sales by Country (2020-2031)
3.7.3 Latin America Assisted Reproductive Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Assisted Reproductive Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Assisted Reproductive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Assisted Reproductive Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Assisted Reproductive Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Assisted Reproductive Drugs Sales by Type (2020-2031)
4.1.1 Global Assisted Reproductive Drugs Sales by Type (2020-2025)
4.1.2 Global Assisted Reproductive Drugs Sales by Type (2026-2031)
4.1.3 Global Assisted Reproductive Drugs Sales Market Share by Type (2020-2031)
4.2 Global Assisted Reproductive Drugs Revenue by Type (2020-2031)
4.2.1 Global Assisted Reproductive Drugs Revenue by Type (2020-2025)
4.2.2 Global Assisted Reproductive Drugs Revenue by Type (2026-2031)
4.2.3 Global Assisted Reproductive Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Assisted Reproductive Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Assisted Reproductive Drugs Sales by Application (2020-2031)
5.1.1 Global Assisted Reproductive Drugs Sales by Application (2020-2025)
5.1.2 Global Assisted Reproductive Drugs Sales by Application (2026-2031)
5.1.3 Global Assisted Reproductive Drugs Sales Market Share by Application (2020-2031)
5.2 Global Assisted Reproductive Drugs Revenue by Application (2020-2031)
5.2.1 Global Assisted Reproductive Drugs Revenue by Application (2020-2025)
5.2.2 Global Assisted Reproductive Drugs Revenue by Application (2026-2031)
5.2.3 Global Assisted Reproductive Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Assisted Reproductive Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Company Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Assisted Reproductive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Serono Assisted Reproductive Drugs Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 MSD
6.2.1 MSD Company Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Assisted Reproductive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MSD Assisted Reproductive Drugs Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 Livzon Pharmaceutical
6.3.1 Livzon Pharmaceutical Company Information
6.3.2 Livzon Pharmaceutical Description and Business Overview
6.3.3 Livzon Pharmaceutical Assisted Reproductive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Livzon Pharmaceutical Assisted Reproductive Drugs Product Portfolio
6.3.5 Livzon Pharmaceutical Recent Developments/Updates
6.4 Xianju Pharmaceutical
6.4.1 Xianju Pharmaceutical Company Information
6.4.2 Xianju Pharmaceutical Description and Business Overview
6.4.3 Xianju Pharmaceutical Assisted Reproductive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Xianju Pharmaceutical Assisted Reproductive Drugs Product Portfolio
6.4.5 Xianju Pharmaceutical Recent Developments/Updates
6.5 Kinsey Pharmaceuticals
6.5.1 Kinsey Pharmaceuticals Company Information
6.5.2 Kinsey Pharmaceuticals Description and Business Overview
6.5.3 Kinsey Pharmaceuticals Assisted Reproductive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kinsey Pharmaceuticals Assisted Reproductive Drugs Product Portfolio
6.5.5 Kinsey Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Assisted Reproductive Drugs Industry Chain Analysis
7.2 Assisted Reproductive Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Assisted Reproductive Drugs Production Mode & Process Analysis
7.4 Assisted Reproductive Drugs Sales and Marketing
7.4.1 Assisted Reproductive Drugs Sales Channels
7.4.2 Assisted Reproductive Drugs Distributors
7.5 Assisted Reproductive Drugs Customer Analysis
8 Assisted Reproductive Drugs Market Dynamics
8.1 Assisted Reproductive Drugs Industry Trends
8.2 Assisted Reproductive Drugs Market Drivers
8.3 Assisted Reproductive Drugs Market Challenges
8.4 Assisted Reproductive Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck Serono
MSD
Livzon Pharmaceutical
Xianju Pharmaceutical
Kinsey Pharmaceuticals
List of Tables
 Table 1. Global Assisted Reproductive Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Assisted Reproductive Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Assisted Reproductive Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Assisted Reproductive Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Assisted Reproductive Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Assisted Reproductive Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Assisted Reproductive Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Assisted Reproductive Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Assisted Reproductive Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Assisted Reproductive Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Assisted Reproductive Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Assisted Reproductive Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Assisted Reproductive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Assisted Reproductive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Assisted Reproductive Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Assisted Reproductive Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Assisted Reproductive Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Assisted Reproductive Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Assisted Reproductive Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Assisted Reproductive Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Assisted Reproductive Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Assisted Reproductive Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Assisted Reproductive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Assisted Reproductive Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Assisted Reproductive Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Assisted Reproductive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Assisted Reproductive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Assisted Reproductive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Assisted Reproductive Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Assisted Reproductive Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Assisted Reproductive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Assisted Reproductive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Assisted Reproductive Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Assisted Reproductive Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Assisted Reproductive Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Assisted Reproductive Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Assisted Reproductive Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Assisted Reproductive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Assisted Reproductive Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Assisted Reproductive Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Assisted Reproductive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Assisted Reproductive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Assisted Reproductive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Assisted Reproductive Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Assisted Reproductive Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Assisted Reproductive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Assisted Reproductive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Assisted Reproductive Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Assisted Reproductive Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Assisted Reproductive Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Assisted Reproductive Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Assisted Reproductive Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Assisted Reproductive Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Assisted Reproductive Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Assisted Reproductive Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Assisted Reproductive Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Assisted Reproductive Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Assisted Reproductive Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Assisted Reproductive Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Assisted Reproductive Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Assisted Reproductive Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Assisted Reproductive Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Assisted Reproductive Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Assisted Reproductive Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Assisted Reproductive Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Assisted Reproductive Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Assisted Reproductive Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Serono Company Information
 Table 71. Merck Serono Description and Business Overview
 Table 72. Merck Serono Assisted Reproductive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Serono Assisted Reproductive Drugs Product
 Table 74. Merck Serono Recent Developments/Updates
 Table 75. MSD Company Information
 Table 76. MSD Description and Business Overview
 Table 77. MSD Assisted Reproductive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. MSD Assisted Reproductive Drugs Product
 Table 79. MSD Recent Developments/Updates
 Table 80. Livzon Pharmaceutical Company Information
 Table 81. Livzon Pharmaceutical Description and Business Overview
 Table 82. Livzon Pharmaceutical Assisted Reproductive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Livzon Pharmaceutical Assisted Reproductive Drugs Product
 Table 84. Livzon Pharmaceutical Recent Developments/Updates
 Table 85. Xianju Pharmaceutical Company Information
 Table 86. Xianju Pharmaceutical Description and Business Overview
 Table 87. Xianju Pharmaceutical Assisted Reproductive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Xianju Pharmaceutical Assisted Reproductive Drugs Product
 Table 89. Xianju Pharmaceutical Recent Developments/Updates
 Table 90. Kinsey Pharmaceuticals Company Information
 Table 91. Kinsey Pharmaceuticals Description and Business Overview
 Table 92. Kinsey Pharmaceuticals Assisted Reproductive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Kinsey Pharmaceuticals Assisted Reproductive Drugs Product
 Table 94. Kinsey Pharmaceuticals Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Assisted Reproductive Drugs Distributors List
 Table 98. Assisted Reproductive Drugs Customers List
 Table 99. Assisted Reproductive Drugs Market Trends
 Table 100. Assisted Reproductive Drugs Market Drivers
 Table 101. Assisted Reproductive Drugs Market Challenges
 Table 102. Assisted Reproductive Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Assisted Reproductive Drugs
 Figure 2. Global Assisted Reproductive Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Assisted Reproductive Drugs Market Share by Type: 2024 & 2031
 Figure 4. Ovulation Stimulation Drugs Product Picture
 Figure 5. Luteal Support Medications Product Picture
 Figure 6. Downregulatory Drugs Product Picture
 Figure 7. Ovulation Inducing Drugs Product Picture
 Figure 8. Global Assisted Reproductive Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Assisted Reproductive Drugs Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Research Institute
 Figure 12. Others
 Figure 13. Global Assisted Reproductive Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Assisted Reproductive Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Assisted Reproductive Drugs Sales (2020-2031) & (K Units)
 Figure 16. Global Assisted Reproductive Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 17. Assisted Reproductive Drugs Report Years Considered
 Figure 18. Assisted Reproductive Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Assisted Reproductive Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Assisted Reproductive Drugs Players: Market Share by Revenue in Assisted Reproductive Drugs in 2024
 Figure 21. Assisted Reproductive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Assisted Reproductive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Assisted Reproductive Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Assisted Reproductive Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. United States Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Assisted Reproductive Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Assisted Reproductive Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Assisted Reproductive Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Assisted Reproductive Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Assisted Reproductive Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Assisted Reproductive Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Assisted Reproductive Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Assisted Reproductive Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Assisted Reproductive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Assisted Reproductive Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Assisted Reproductive Drugs by Type (2020-2031)
 Figure 55. Global Assisted Reproductive Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Assisted Reproductive Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Assisted Reproductive Drugs by Application (2020-2031)
 Figure 58. Global Assisted Reproductive Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 59. Assisted Reproductive Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Assisted Reproductive Medications Market Research Report 2024
Global Fertility Drugs Market Insights Forecast to 2030
Global Infertility Treatment Drugs Market Insights Forecast to 2030
Global Fertility Enhancing Treatment Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Infertility Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Assisted Reproductive Technologies Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Female Infertility Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproduction Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Technology Drugs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Assisted Reproductive Treatment Market Research Report 2024
Assisted Reproductive Technologies Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Medical Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Assisted Reproductive Products Market Research Report 2024
Global Injectable Fertility Medications Market Research Report 2024
Global Ovulation Inducing Drugs Market Research Report 2024
Assistive Reproductive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assistive Reproductive Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable IVF Medications Market Research Report 2024
Global Liquid Products for Assisted Reproductive Market Research Report 2024
IVF Devices and Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions